https://pipelinereview.com/fda-approves-vonvendi-von-willebrand-factor-recombinant-for-perioperative-management-of-bleeding-in-adult-patients-with-von-willebrand-disease1/
FDA approves Vonvendi [von Willebrand factor (recombinant)] for perioperative management of bleeding in adult patients with von Willebrand disease1